By Marisa Wong
Morgantown, W.Va., Nov. 5 – China Resources Pharmaceutical Group Ltd.’s wholly owned subsidiary, China Resources Pharmaceutical Holdings Co. Ltd., issued RMB 2 billion of three-year notes with a coupon of 4.04% on Monday, according to a notice.
The company had announced on Aug. 17 plans to issue up to RMB 12 billion of medium-term notes in China within two years. This is the company’s second tranche. The first tranche, RMB 2 billion of 4.21% three-year notes, was issued on Aug. 27.
Funds raised will be used mainly to replenish the working capital of China Resources Pharmaceutical Commercial Group Co. Ltd., an indirect wholly owned subsidiary of China Resources Pharmaceutical Holdings.
The pharmaceutical company has offices in Hong Kong and Beijing.
| Issuer: | China Resources Pharmaceutical Holdings Co. Ltd.
|
| Issue: | Medium-term notes, 2018 second tranche
|
| Amount: | RMB 2 billion
|
| Maturity: | Three years
|
| Coupon: | 4.04%
|
| Settlement date: | Nov. 5
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
